Trip is accomplished leader with deep experience developing high-growth healthcare companies. Trip previously served as President of Accordant Health, a CVS/specialty company, and held senior leadership roles at OptumHealth and Health Dialog. He holds a bachelor’s degree from St. Lawrence University and an MBA from Yale University’s School of Management.
Dan is a transformational operating executive with over 20 years of experience scaling companies from earlier-stage ventures to multi-billion dollar healthcare enterprises in the U.S. payer, provider, and patient engagement services sectors. Dan graduated with a BSE and an MBA from the Wharton School of Business at the University of Pennsylvania.
Reena leads AbleTo’s data analytics and outcomes research and is a passionate voice for mental health parity. She is a cardiologist and trained at Brigham and Women's Hospital and Harvard Medical School.
Aimee is a Licensed Clinical Social Worker (LCSW) and uses her position to assist individuals to overcome barriers to life aspirations. Aimee leads the development and oversight of all clinical programs, as well as clinical training for AbleTo’s national therapist and behavior coach network.
Dorothy is a 25-year healthcare industry leader who has led several commercial teams within high-growth companies. Prior to joining AbleTo, Dorothy served as a Senior Vice President at Practice Fusion, President of Havas Life, and in a variety of senior leadership roles at WebMD.
Jon is a passionate business leader with an innate ability to approach complex healthcare topics with authenticity and integrity. Prior to joining AbleTo, Jon held leadership positions at Horizon Blue Cross Blue Shield of New Jersey, where he led the development and execution of enterprise-wide strategies.
Renee is a leader in financial and strategic management in the healthcare field. Before joining AbleTo, she directed the global financial and strategic planning group at Eli Lilly. Renee has also served as CFO of Lilly’s sales and marketing affiliates in Austria & Switzerland.
Frank brings a passionate and experienced leadership focus to the financial and accounting team. Combining financial disciple with an operational focus, Frank leads teams through rapid growth stages. Before joining AbleTo, he was CFO of Connotate, Inc. and CAO of both Reval.com and Centennial Communications. At Centennial, Frank lead the Accounting organization from a cable company subsidiary with $100 million in revenue to a $1.1 billion Private Equity backed public company sold to AT&T in 2010.
Lloyd is an innovative technology leader with more than 25 years delivering disruptive healthcare optimization solutions across the continuum of care. Prior to AbleTo, he led technology for Imaging Advantage, Advanced Monitored Caregiving, and Vizient.
Pat is an innovative leader with over 22 years of experience in go to market strategy, sales and account management. Prior to joining AbleTo, Pat spent the last 12 years leading sales for high-growth healthcare businesses at Hometeam, EXL and Accenture as a Managing Director and Sales Lead for the North American Health practice.
Not only does Liam offer years of experience as a venture investor, he also started 4 successful businesses, including .406 Ventures where he serves as Co-Founder and Managing Partner. There, he leads all healthcare investments focusing on technology-enabled solutions.
After joining Sandbox Industries in 2008, Tom has served as Managing Director and a member of the fund management committee. With an MD, an MBA, and a wealth of knowledge and experience in healthcare, he proudly joined the AbleTo Board in 2014.
Russ has a wide range of experience managing, consulting, and advising emerging health companies. He most recently served as Global Managing Director for Accenture’s Health industry and the United States Managing Director of Accenture’s Health Payer practice.
Yumin leads the healthcare team of Bain Capital Ventures and previously worked as General Partner for HLM Venture Partners where he focused on healthcare IT.
Enrico serves as a Venture Partner for HLM and previously co-founded HTS Biosystems, Inc. He has a strong history of developing new technologies that advance healthcare, earning him 9 patents and a recognition from the Smithsonian Institute for his achievements in PCR technology.